These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4978153)

  • 21. [Experimental tuberculosis infection of guinea pigs in the necropsy room and examination of infection risk using guinea pigs with tuberculosis].
    Shishido S; Mori T; Kawai M
    Kekkaku; 1994 Sep; 69(9):543-7. PubMed ID: 7967314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening of Bacillus strains as potential probiotics and subsequent confirmation of the in vivo effectiveness of Bacillus subtilis MA139 in pigs.
    Guo X; Li D; Lu W; Piao X; Chen X
    Antonie Van Leeuwenhoek; 2006 Aug; 90(2):139-46. PubMed ID: 16820971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fluctuation in the ratio between drug-resistant and -susceptible M. tuberculosis bacilli which were isolated from patients with prolonged anti-tuberculosis treatment].
    Ano H; Matsumoto T; Yoshida H; Ishida C; Tanigawa N; Kawahara K; Toba H; Takashima T; Tsuyuguchi I
    Kekkaku; 2003 Dec; 78(12):739-46. PubMed ID: 14733114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Results of treatment of experimental tuberculosis in guinea pigs with isoniazid or with isoniazid combined with ethambutol, either in continous or in intermittent regimen].
    Sosnowski W; Rozniecki J; Tomaszkiewicz L; Bechcińska B; Cyperling I
    Gruzlica; 1970 Jan; 38(1):35-42. PubMed ID: 4984432
    [No Abstract]   [Full Text] [Related]  

  • 25. [Course of experimental tuberculosis in guinea pigs infected per os with a single dose of the H37 Rv bacilli].
    Fafrowicz B
    Gruzlica; 1966 Jan; 34(1):27-30. PubMed ID: 5910741
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental studies on the effect of subtivaccine on the course of anaphylactic shock].
    Jankowiak J; Straburzyński G
    Acta Physiol Pol; 1965; 16(4):497-504. PubMed ID: 4958227
    [No Abstract]   [Full Text] [Related]  

  • 27. THE FOCUS OF INOCULATION IN GUINEA PIGS DURING TREATMENT WITH MORFOZINAMIDE. (INFECTION WITH STRAINS SENSITIVE AND RESISTANT TO CHEMOTHERAPY AND ANTIBIOTICS.
    CATENA E; ALIPERTA A; ROCCO V
    Arch Tisiol Mal Appar Respir; 1963 Apr; 18():366-77. PubMed ID: 14055802
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of different isoniazid concentrations on the Mycobacterium tuberculosis variant highly resistant to the preparation].
    Bondarev IM; Dolgaia TM
    Probl Tuberk; 1980 Aug; (8):65-9. PubMed ID: 6773048
    [No Abstract]   [Full Text] [Related]  

  • 29. Symposium on drug resistant tuberculosis. Reserve drug combinations.
    Mitchison DA
    J Ir Med Assoc; 1970 Mar; 63(393):86-91. PubMed ID: 4984341
    [No Abstract]   [Full Text] [Related]  

  • 30. Lysine excretion by S-(2-aminoethyl)L-cysteine resistant mutants of Bacillus subtilis.
    Chaudhuri A; Mishra AK; Nanda G
    Acta Microbiol Pol; 1983; 32(1):37-45. PubMed ID: 6194664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The virulence of Mycobacterium tuberculosis strains resistant to rifampicin. (Preliminary note)].
    Daddi G; Lucchesi M; Mancini P; Termine A
    Ann Ist Carlo Forlanini; 1969; 29(1):29-33. PubMed ID: 4996681
    [No Abstract]   [Full Text] [Related]  

  • 32. [Biological characteristics of rifampicin-resistant Mycobacterium tuberculosis].
    Klimenko MT
    Antibiotiki; 1984 Mar; 29(3):185-8. PubMed ID: 6428304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Discrepancy between drug resistance of mycobacterium tuberculosis determined in vitro and in vivo].
    Belogurova VP; Gorislavets II; Ivanitskaia NN
    Probl Tuberk; 1971; 49(6):76-80. PubMed ID: 5000746
    [No Abstract]   [Full Text] [Related]  

  • 34. [Overview on preclinical research on tuberculosis chemotherapy in the past 100 years. (2) Experimental studies following clinical tests].
    Kanei T; Kondo E
    Kekkaku; 1983 Apr; 58(4):235-45. PubMed ID: 6632485
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterization of D-cycloserine resistant mutants in Bacillus subtilis.
    Gallori E; Fani R
    Microbiologica; 1983 Jan; 6(1):19-26. PubMed ID: 6405128
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bacillus subtilis mutants resistant to roseoflavin].
    Kukanova AIa; Zhdanov VG; Stepanov AI
    Genetika; 1982 Feb; 18(2):319-21. PubMed ID: 6800882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virulence attenuation and other biological modifications in multiple drug resistant tubercle mycobacteria.
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P; Serafini NA; Termine A; Zubiani M
    Boll Ist Sieroter Milan; 1971; 50(4):353-61. PubMed ID: 5005885
    [No Abstract]   [Full Text] [Related]  

  • 38. [In vivo and in vitro experimental research on polyresistant Mycobacterium tuberculosis].
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Termine A
    Ann Ist Carlo Forlanini; 1969; 29(4):301-16. PubMed ID: 5004329
    [No Abstract]   [Full Text] [Related]  

  • 39. [Animal experimental studies on the effect of rifampicin on pathogenic gas gangrene bacilli].
    Schallehn G
    Schweiz Med Wochenschr; 1969 Jul; 99(29):1057-9. PubMed ID: 5802010
    [No Abstract]   [Full Text] [Related]  

  • 40. [Study of the virulence and toxic properties of M. tuberculosis sensitive and resistant to antitubercular agents].
    Ginzburg TS; Klimenko MT
    Probl Tuberk; 1983 Jan; (1):63-7. PubMed ID: 6402771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.